FDA Overseas Staff Lacks Coordination With Agency's Centers, GAO Says
Executive Summary
FDA has no formal process for reviewing and incorporating information provided by its overseas staff into the selection of foreign drug establishments for inspection, according to the Government Accountability Office.
You may also be interested in...
FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan
Agency wants to target supply-chain threats and help judge the value of information received from third-party inspections.
FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model
FDA would gain a boost in funding for overseas manufacturing facility inspections in President Obama’s fiscal year 2012 budget, even though the agency has acknowledged its model is unsustainable and is planning changes.
FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model
FDA would gain a boost in funding for overseas manufacturing facility inspections in President Obama’s fiscal year 2012 budget, even though the agency has acknowledged its model is unsustainable and is planning changes.